Following a strategic review of its Health division in April, Johnson Matthey (JM) has agreed to sell a majority stake in the business to US investment company Altaris...
Following a recommendation by the European Medicines Agency (EMA), the European Commission has granted conditional marketing authorization to the protein-based Covid-19...
With the fast rolling wave of yet another Coronavirus variant sparking global concern, vaccine mandates, booster shots and efficacy studies are dominating headlines in...
Danish biotech Novozymes and Italian engineering company Saipem have agreed to collaborate on the development and commercialization of an enzymatic carbon capture process...
Novartis and market watchers alike have been dropping repeated hits that a sale of the Swiss drugs giant’s Sandoz-branded generic drugs arm may be closer than has been...
Germany’s Merck is allocating an additional €600 million to its strategic corporate venture capital arm M Ventures. The chemicals, pharmaceuticals and life sciences group...
Swiss CDMO Lonza has agreed a five-year collaboration on the development and manufacturing of biologics and small molecules with European venture capital firm Bioqube...
Fujifilm Diosynth Biotechnologies is investing £400 million to expand its Teesside site in northeast England, where it makes the active ingredient for the Novavax Covid...
Britain’s largest drugmaker, GlaxoSmithKline (GSK) has landed a major coup, luring Pfizer’s vaccines R&D chief away, as it tries to regain its position in the top tier of...
US food and nutrition group ADM has acquired Sojaprotein, a Serbian-based provider of non-GMO soy ingredients, for an undisclosed sum. The acquisition expands ADM’s...
